News
Rusan Pharma’s 2baconil launches Anthem-Led “2baconil Kar, Zindagi Fulfil Kar” campaign on World No Tobacco Day 2025: Our ...
IDMA appoints Nikkhil K Masurkar as vice chairperson of R&D and Innovation Committee: Our Bureau, Mumbai Friday, May 30, 2025 ...
Telangana IDMA elects KV Rambabu of Pulse Pharma as president, Sekhar Rao of TherDose Pharma new secretary: Our Bureau, ...
Auron Announces begins patient dosing in phase 1 trial of AUTX-703 in advanced hematologic malignancies: Newton, Massachusetts Friday, May 30, 2025, 18:00 Hrs [IST] Auron Therapeu ...
ICMR releases two books on Indian Medicinal Plants for drug development and valuable in regulatory submissions: Our Bureau, Bengaluru Friday, May 30, 2025, 16:15 Hrs [IST] Indian ...
US FDA grants priority review status to Bayer’s sevabertinib to treat patients with HER2-mutant non-small cell lung cancer: Berlin Friday, May 30, 2025, 16:00 Hrs [IST] Bayer an ...
Hyderabad-based Natco Pharma has reported a profit after tax (PAT) growth of 5 per cent at Rs. 406 crore during the quarter ended March 31, 2025, as compared to Rs. 386.3 crore during the same period ...
Our Bureau, New Delhi Friday, May 30, 2025, 14:15 Hrs [IST] Alkem Laboratories has reported a growth of 6 per cent in ...
Sir H N Reliance Foundation Hospital launches South Asia’s first Genius AI 3D Mammography System: Our Bureau, Mumbai Friday, May 30, 2025, 15:50 Hrs [IST] In a pioneering advanc ...
GSK & Spero Therapeutics announce PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by IDMC: London, UK Friday, May 30, 2025, 15:00 Hrs [IST] ...
PepGen to focus on development of DM1 programme following 10 mg/kg PGN-EDO51 update: Boston Friday, May 30, 2025, 14:00 Hrs [IST] PepGen Inc, a clinical-stage biotechnology compan ...
Eton Pharmaceuticals’ NDA for Khindivi receives US FDA nod for oral solution formulation: Deer Park, Illinois Friday, May 30, 2025, 13:00 Hrs [IST] Eton Pharmaceuticals, Inc, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results